Диптивил

Диптивил (Vildagliptin) is an oral antidiabetic medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to the DPP-4 inhibitor class, supporting glycemic control alongside diet and exercise. This EU-manufactured generic provides a convenient once-daily option for diabetes management.

Vildagliptin is prescribed to improve blood sugar control in adults with type 2 diabetes, particularly when diet and exercise alone are insufficient. It works by increasing incretin levels, which help regulate insulin release after meals. This medication is often used as part of a combination therapy, including metformin or sulfonylureas, to enhance glycemic stability. Patients often ask, 'What is Vildagliptin used for?' to understand its role in diabetes care.

Vildagliptin helps maintain steady blood sugar levels throughout the day, reducing spikes after meals. Many users report improved energy and reduced fatigue associated with high blood sugar. Some may notice better overall glucose control within weeks of starting treatment. Individual responses vary, and effects depend on adherence to prescribed therapy.

Store Диптивил at room temperature, away from moisture and direct light. Keep this medication out of reach of children and pets. Always inform your healthcare provider about all current medications and health conditions before starting treatment. Regular blood sugar monitoring is recommended to assess effectiveness.

Vildagliptin may interact with other diabetes medications, such as insulin or sulfonylureas, potentially increasing the risk of low blood sugar. Alcohol and certain diuretics can also affect blood glucose levels. Inform your doctor if you take ACE inhibitors, as they may influence kidney function. Always review your full medication list with a healthcare professional.